Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, United States.
Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, United States
BMJ Case Rep. 2020 Sep 9;13(9):e234764. doi: 10.1136/bcr-2020-234764.
A 49-year-old woman, previously healthy, presented with recurrent fractures provoked by minimal trauma. She had sustained seven fractures over the previous 2 years. While she was an avid runner, her injuries were determined to be out of proportion to the degree of trauma. Initial evaluation, exploring the more common causes such as low bone density and abnormal vitamin D metabolism, was unremarkable. On repeat of the some of the tests, a low alkaline phosphatase (AP) was noted, which raised suspicion for hypophosphatasia (HPP), a rare cause of recurrent fractures. Subsequent workup revealed a low bone-specific AP and elevated vitamin B Subsequently, genetic testing confirmed the diagnosis of adult-onset HPP caused by a heterozygous mutation c.407G>A in the ALPL gene. Asfotase alfa was started; however, the patient developed an allergic reaction leading to the discontinuation of the drug.
一位 49 岁的既往健康女性,因轻微创伤反复发生骨折而就诊。在过去 2 年中,她已发生 7 次骨折。尽管她热衷于跑步,但她的损伤与创伤程度不成比例。最初的评估,包括更常见的病因,如骨密度低和异常维生素 D 代谢,均无明显异常。在重复部分检查时,发现碱性磷酸酶(AP)水平低,这提示存在低磷酸酶血症(HPP)的可能,这是一种罕见的复发性骨折原因。进一步检查发现骨特异性 AP 水平低,维生素 B 水平升高。随后,基因检测证实了由 ALPL 基因的杂合突变 c.407G>A 引起的成人发病型 HPP 的诊断。开始使用阿法磷酸酶,但患者发生过敏反应,导致药物停用。